Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Gains from Sales and Divestitures (2016 - 2025)

Historic Gains from Sales and Divestitures for Theravance Biopharma (TBPH) over the last 10 years, with Q3 2025 value amounting to $336744.0.

  • Theravance Biopharma's Gains from Sales and Divestitures rose 1327.35% to $336744.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $336744.0, marking a year-over-year increase of 1327.35%. This contributed to the annual value of $1.6 million for FY2024, which is 64.29% down from last year.
  • As of Q3 2025, Theravance Biopharma's Gains from Sales and Divestitures stood at $336744.0, which was up 1327.35% from $413240.0 recorded in Q2 2025.
  • Theravance Biopharma's 5-year Gains from Sales and Divestitures high stood at $3.8 million for Q4 2022, and its period low was $297284.0 during Q3 2024.
  • In the last 5 years, Theravance Biopharma's Gains from Sales and Divestitures had a median value of $619026.0 in 2025 and averaged $1.3 million.
  • Per our database at Business Quant, Theravance Biopharma's Gains from Sales and Divestitures surged by 4062.69% in 2021 and then plummeted by 5616.68% in 2023.
  • Quarter analysis of 5 years shows Theravance Biopharma's Gains from Sales and Divestitures stood at $2.7 million in 2021, then surged by 40.44% to $3.8 million in 2022, then crashed by 56.17% to $1.7 million in 2023, then dropped by 0.64% to $1.6 million in 2024, then tumbled by 79.47% to $336744.0 in 2025.
  • Its last three reported values are $336744.0 in Q3 2025, $413240.0 for Q2 2025, and $619026.0 during Q1 2025.